Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Educational Intervention to Increase Adoption of Selective Laser Trabeculoplasty as First-Line Treatment for Glaucoma

NCT03365778 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.

NCT NCT03365778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03365778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Educational Intervention to Increase Adoption of Selective Laser Trabeculoplasty as First-Line Treatment for Glaucoma
Lead sponsor
Wills Eye
Phase
Not applicable
Overall status
Completed
Start date
October 23, 2017
Completion date
December 31, 2019
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary open-angle glaucoma